Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma

Leukemia Research

Volumn 34, Issue 7, 2010, Pages 932-938

  Rütgen, Barbara C ^a   Hammer, Sabine E ^a   Gerner, Wilhelm ^a   Christian, Maria ^a   de Arespacochaga, Abigail Guija ^a   Willmann, Michael ^a   Kleiter, Miriam ^a   Schwendenwein, Ilse ^a   Saalmüller, Armin ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Canine B cell lymphoma; Cell line; Flow cytometry; PARR

Indexed keywords

ANTIGEN; CD11D ANTIGEN; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD79 ALPHACGAMMA; CD8 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL STRUCTURE; DNA SEQUENCE; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOID CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; BIOPSY, FINE-NEEDLE; CELL LINE, TUMOR; CELL SEPARATION; CLONE CELLS; DOG DISEASES; DOGS; FLOW CYTOMETRY; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; NEOPLASM PROTEINS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 77952959216     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.01.021     Document Type: Article

References (21)

1. Pastor M., Chalvet-Monfray K., Marchal T., Keck G., Magnol J.P., Fournel-Fleury C., et al. Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year. J Vet Intern Med 2009, 23:301-310.
2. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000, 18:781-792.
3. Ogilvie G.K., Moore A.S. Managing the veterinary cancer patient-a practical manual 1996, VIS Book, p. 228-49.
4. Kessler M. Kleintieronkologie-Diagnose und Therapie von Tumorerkrankungen bei Hunden und Katzen. Parey, Blackwell Wissenschaft; 1999. p. 523-51.
5. Mack G.S. Cancer researchers usher in dog days of medicine. Nat Med 2005, 11:1018.
6. Khanna C., Lindblad-Toh K., Vail D., London C., Bergman P., Barber L., et al. The dog as a cancer model. Nat Biotechnol 2006, 24:1065-1066.
7. Greenlee P.G., Filippa D.A., Quimby F.W., Patnaik A.K., Calvano S.E., Matus R.E., et al. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 1990, 66:480-490.
8. Teske E. Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma. Vet Q 1994, 16:209-219.
9. Fournel-Fleury C., Magnol J.P., Bricaire P., Marchal T., Chabanne L., Delverdier A., et al. Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas. J Comp Pathol 1997, 117:35-59.
10. Thomas R., Smith K.C., Ostrander E.A., Galibert F., Breen M. Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer 2003, 89:1530-1537.
11. Fosmire S.P., Thomas R., Jubala C.M., Wojcieszyn J.W., Valli V.E., Getzy D.M., et al. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet Pathol 2007, 44:467-478.
12. Breen M., Modiano J.F. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans-man and his best friend share more than companionship. Chromosome Res 2008, 16:145-154.
13. Drexler H.G. The leukemia-lymphoma cell line facts book 2001, Academic Press, San Diego, CA.
14. Momoi Y., Okai Y., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma. Vet Immunol Immunopathol 1997, 59:11-20.
15. Nakaichi M., Taura Y., Kanki M., Mamba K., Momoi Y., Tsujimoto H., et al. Establishment and characterization of a new canine B-cell leukemia cell line. J Vet Med Sci 1996, 58:469-471.
16. Kisseberth W.C., Nadella M.V.P., Breen M., Thomas R., Duke S.E., Murahari S., et al. A novel canine lymphoma cell line: a translational and comparative model for lymphoma research. Leuk Res 2007, 31:1709-1720.
17. Davis J. Basic cell culture: A practical approach 2002, Oxford University Press, p. 167.
18. Saalmüller A., Lunney J.K., Daubenberger C., Davis W., Fischer U., Göbel T.W., et al. Summary of the animal homologue section of HLDA8. Cell Immunol 2005, 236:51-58.
19. Burnett R.C., Vernau W., Modiano J.F., Olver C.S., Moore P.F., Avery A.C. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol 2003, 40:32-41.
20. Davis R.E., Brown K.D., Siebenlist U., Staudt L.M. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. JEM 2001, 194:1861-1874.
21. Blenk S., Engelmann J., Weniger M., Schultz J., Dittrich M., Rosenwald A., et al. Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform 2007, 3:399-420.